134 related articles for article (PubMed ID: 36602672)
21. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
Chang Y; Li N; Yuan W; Wang G; Wen J
Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
[TBL] [Abstract][Full Text] [Related]
22. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
23. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53.
Yang Y; Luo Y; Huang S; Tao Y; Li C; Wang C
Cancer Biomark; 2023; 36(4):267-278. PubMed ID: 36938725
[TBL] [Abstract][Full Text] [Related]
24. MEK drives cyclin D1 hyperelevation during geroconversion.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Death Differ; 2013 Sep; 20(9):1241-9. PubMed ID: 23852369
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
[No Abstract] [Full Text] [Related]
26. Epigenetic inactivation of ACAT1 promotes epithelial-mesenchymal transition of clear cell renal cell carcinoma.
Han P; Wu S; Li L; Li D; Zhao J; Zhang H; Wang Y; Zhong X; Zhang Z; Li P; Matskova L; Zhou X
Genes Genomics; 2022 Apr; 44(4):487-497. PubMed ID: 34985712
[TBL] [Abstract][Full Text] [Related]
27. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
28. MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma.
Fang J; Zhen J; Gong Y; Ke Y; Fu B; Jiang Y; Xie J; Liu Y; Ding Y; Huang D; Xiao F
Aging (Albany NY); 2022 Sep; 14(18):7416-7442. PubMed ID: 36098680
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
[TBL] [Abstract][Full Text] [Related]
30. circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma.
Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cancer Sci; 2019 Feb; 110(2):568-581. PubMed ID: 30520539
[TBL] [Abstract][Full Text] [Related]
31. RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
Li D; Tang L; Liu B; Xu S; Jin M; Bo W
Aging (Albany NY); 2021 Mar; 13(7):10450-10467. PubMed ID: 33790054
[No Abstract] [Full Text] [Related]
32. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
[TBL] [Abstract][Full Text] [Related]
33. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
[TBL] [Abstract][Full Text] [Related]
34. MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma.
Liang J; Zhang Y; Jiang G; Liu Z; Xiang W; Chen X; Chen Z; Zhao J
Oncol Res; 2013; 21(2):83-91. PubMed ID: 24406044
[TBL] [Abstract][Full Text] [Related]
35. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
Stein GH; Drullinger LF; Soulard A; Dulić V
Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
[TBL] [Abstract][Full Text] [Related]
36. Cyclin F: A component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer.
Galper J; Rayner SL; Hogan AL; Fifita JA; Lee A; Chung RS; Blair IP; Yang S
Int J Biochem Cell Biol; 2017 Aug; 89():216-220. PubMed ID: 28652210
[TBL] [Abstract][Full Text] [Related]
37. SCYL1-BP1 affects cell cycle arrest in human hepatocellular carcinoma cells via Cyclin F and RRM2.
Wang Y; Zhi Q; Ye Q; Zhou C; Zhang L; Yan W; Wu Q; Zhang D; Li P; Huo K
Anticancer Agents Med Chem; 2016; 16(4):440-6. PubMed ID: 25980818
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of
Yang CA; Huang HY; Yen JC; Chang JG
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843367
[TBL] [Abstract][Full Text] [Related]
39. miR-138-5p inhibits proliferation and invasion in kidney renal clear cell carcinoma by targeting SINA3 and regulation of the Notch signaling pathway.
Liu Y; Qu HC
J Clin Lab Anal; 2021 Nov; 35(11):e23766. PubMed ID: 34586647
[TBL] [Abstract][Full Text] [Related]
40. Mutant p53 can delay growth arrest and loss of CDK2 activity in senescing human fibroblasts without reducing p21(WAF1) expression.
Wyllie F; Haughton M; Bartek J; Rowson J; Wynford-Thomas D
Exp Cell Res; 2003 May; 285(2):236-42. PubMed ID: 12706118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
